Aug 04, 2021 / 08:30PM GMT
Operator
Good afternoon, ladies and gentlemen, and thank you for standing by, and welcome to the Second Quarter 2021 Xencor Conference Call. (Operator Instructions) Please be advised that this call is being recorded at the company's request.
Now I would like to turn the call over to your speaker for today, Charles Liles, Head of Corporate Communications and Investor Relations.
Charles Liles - Xencor, Inc. - Associate Director and Head of Corporate Communications & IR
Thank you, and good afternoon. Earlier today, we issued a press release which outlines the topics we plan to discuss today. It's available at www.xencor.com.
Today on our call, Bassil Dahiyat, President and Chief Executive Officer, will review recent business news and pipeline updates; John Desjarlais, Chief Scientific Officer, will discuss our cytokine and CD28 programs; and John Kuch, Chief Financial Officer, will review financial results. And then we'll open up the call for your questions. And Allen Yang, Chief Medical
Q2 2021 Xencor Inc Earnings Call Transcript
Feb 09, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers